Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.08
(
0.87%
)
Bitcoin
68,316.15
(
0.70%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biopearl post# 5689

Thursday, 11/22/2007 10:51:40 PM

Thursday, November 22, 2007 10:51:40 PM

Post# of 19309
Re: Financing

>Let me know if you think this "gap" would be closed by the partner to allow ongoing operations until US sales ramp up.<

There are too many variables to say with a high degree of confidence. However, the implicit message in Jack Green’s comment in the iBox is that FDA approval of ATryn will be enough of a market-moving event to make raising capital on favorable terms relatively straightforward.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up